Flumatinib is a tyrosine kinase inhibitor primarily indicated for the treatment of ALK-positive non-small cell lung cancer by targeting and blocking downstream signaling pathways associated with tumor… Read more
Flumatinib is a tyrosine kinase inhibitor primarily indicated for the treatment of ALK-positive non-small cell lung cancer by targeting and blocking downstream signaling pathways associated with tumor growth. This category provides a comprehensive selection of Flumatinib reference standards, including the mesylate salt and various related compounds such as N-desmethyl and N-nitroso impurities. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and routine quality control during the manufacturing process. By utilizing high-quality analytical standards, researchers can ensure compliance with regulatory requirements and maintain precision in their findings. Furthermore, this collection includes stable isotope-labelled compounds, such as deuterated and 13C-labelled analogs, which are critical for the accurate quantification of the drug in complex matrices during LC-MS/MS bioanalytical testing. These reference materials support the development of robust analytical methods throughout the drug lifecycle.